Australia Patent: The Trustees of the University of Pennsylvania, Novartis File Application for 'Treatment of cancer using anti-CD19 chimeric antigen receptor'

Press/Media

PeriodFeb 11 2022

Media coverage

1

Media coverage

  • TitleAustralia Patent: The Trustees of the University of Pennsylvania, Novartis File Application for 'Treatment of cancer using anti-CD19 chimeric antigen receptor'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date02/11/22
    PersonsMariusz A. Wasik